Jonathan D Goodacre - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jonathan D Goodacre

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Chemical Communications (Cambridge, England)|May 24, 2012

Rhodium-catalysed linear-selective alkyne hydroacylationSarah-Jane Poingdestre, Jonathan D Goodacre, Andrew S Weller, et al.

Journal of Medicinal Chemistry|December 6, 2011

Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamidesPaul Bamborough, Hawa Diallo, Jonathan D Goodacre, et al.

Bioorganic & Medicinal Chemistry Letters|September 12, 2020

Structure-based optimisation of orally active & reversible MetAP-2 inhibitors maintaining a tight 'molecular budget'David J Hirst, Martin Brandt, Gordon Bruton, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Chemical Communications (Cambridge, England)|May 24, 2012

Rhodium-catalysed linear-selective alkyne hydroacylationSarah-Jane Poingdestre, Jonathan D Goodacre, Andrew S Weller, et al.

Journal of Medicinal Chemistry|December 6, 2011

Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamidesPaul Bamborough, Hawa Diallo, Jonathan D Goodacre, et al.

Bioorganic & Medicinal Chemistry Letters|September 12, 2020

Structure-based optimisation of orally active & reversible MetAP-2 inhibitors maintaining a tight 'molecular budget'David J Hirst, Martin Brandt, Gordon Bruton, et al.

Pageof 1